Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Clinical trial NCT00879606 · COMPLETED

Trial details

NCT number: NCT00879606
Sponsor: Altor BioScience
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Acute Lung Injury Acute Respiratory Distress Syndrome

Start date: 2009-04-01
Primary completion: 2012-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.